Tag Archives: medical

Researchers engineer ‘Cas9’ animal models to study disease, inform drug discovery

In recent years, genetic studies have found thousands of links between genes and various diseases. But in order to prove that a specific gene is playing a role in the development of the disease, researchers need a way to perturb it — that is, turn the gene off, turn it on, or otherwise alter it — and study the effects. The CRISPR-Cas9 genome-editing system is one of the most convenient methods available for making these alterations in the genome. While the tool is already being used to test the effects of mutations in vitro — in cultured cell lines, for instance — it is now possible to use this tool to study gene functions using intact biological systems…

Study questions accuracy of lung cancer screens in some geographic regions

Histoplasmosis and other fungal diseases are linked to fungi that are often concentrated in bird droppings and are found in soils. The study by investigators at Vanderbilt University and the Tennessee Valley Healthcare System-Veterans Affairs was led by Vanderbilt first author Stephen Deppen, Ph.D., and principal investigator Eric Grogan, M.D., MPH, and appeared in the Sept. 24 issue of JAMA. Positron emission tomography (PET) combined with fludeoxyglucose F18 (FDG) is currently recommended for the noninvasive diagnosis of lung nodules suspicious for lung cancer…

Directed evolution: Bioengineered decoy protein may stop cancer from spreading

This process, known as metastasis, can cause cancer to spread with deadly effect. “The majority of patients who succumb to cancer fall prey to metastatic forms of the disease,” said Jennifer Cochran, an associate professor of bioengineering who describes a new therapeutic approach in Nature Chemical Biology. Today doctors try to slow or stop metastasis with chemotherapy, but these treatments are unfortunately not very effective and have severe side effects…

Urine HPV test could offer non-invasive alternative to conventional smear, improve screening uptake

Current screening by cervical cytology (smear test) is invasive and time-consuming — and in recent years, cervical screening in the UK has fallen below 80%, particularly amongst women aged 25-30. Several studies have suggested that detecting HPV in urine may be a feasible alternative to cervical sampling, but the accuracy of such a test is still uncertain. …

Lactation linked to reduced estrogen receptor-negative, triple-negative breast cancer risk — ScienceDaily

Researchers from Boston University’s Slone Epidemiology Center (SEC) collaborated with the Roswell Park Cancer Institute of Buffalo, NY and the University of North Carolina Lineberger Cancer Center to form a consortium to study the determinants of breast cancer subtypes in African American women. They combined data on breast cancer cases and controls from four large studies, including the Boston University Black Women’s Health Study…

Benefit of endocrine therapy in elderly women with low risk hormone receptor positive breast cancer? — ScienceDaily

The results, which Fox Chase researchers presented at the American Society for Radiation Oncology’s 56th Annual Meeting on September 14, suggest that low-risk patients over 65 years old with small tumors may achieve comparable survival after treatment with adjuvant radiation therapy alone — without undergoing endocrine therapy. …

New radiosurgery technology provides highly accurate treatment, greater patient comfort

The study shows the Edge™ Radiosurgery Suite is able to target cancer tumors within 1 mm, providing sub-millimeter accuracy with extreme precision. “Radiosurgery is just one shot of precision radiation with a very high dose to treat tumors,” says study lead author Ning Wen, Ph.D., a physicist with the Department of Radiation Oncology at Henry Ford. …

Patients with inoperable, early-stage lung cancer who receive stereotactic body radiation therapy have 40% five-year survival rate

RTOG 0236 was a Phase II North American multicenter trial from May 2004 until October 2006 of patients age 18 and older with biopsy-proven peripheral T1-T2 N0M0 non-small cell lung cancer (early stage with no lymph node involvement or metastases). Patients in the study all had medical conditions that precluded them from surgery, so they received SBRT, a specialized type of external beam therapy that uses focused radiation beams at a tumor using detailed imaging…